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Purpose: To retrospectively evaluate the usefulness of virtual fluoroscopic preprocedural 2 
planning (VFPP) in the percutaneous transhepatic biliary drainage (PTBD) procedure. 3 
Materials and Methods: Twenty-two patients who were treated by PTBD were included 4 
in this study. Twelve patients were treated using PTBD intraoperative referencing 5 
coronal computed tomography (CT) images (i.e., coronal CT group), and 10 patients 6 
were treated using PTBD intraoperative referencing VFPP images (i.e., VFPP group). 7 
To analyze the effect of the intraoperative referencing VFPP image, the VFPP group 8 
was retrospectively compared with the coronal CT group. 9 
Results: The characteristics of both patient groups were not statistically significantly 10 
different. There were no significant differences in the targeted bile duct, diameter and 11 
depth of the target bile, breath-holding ability, number of targeted bile duct puncture 12 
attempts, change in the targeted bile duct, and exchange of the drainage catheter. 13 
However, the X-ray fluoroscopy time and the procedure time were significantly shorter 14 
in the VFPP group than in the coronal CT group (196 vs. 334 seconds, P < 0.05; and 15 
16.0 vs. 27.2 minutes, P < 0.05). 16 
Conclusion: Intraoperative referencing using the VFPP imaging in PTBD intuitively can 17 
be a useful tool for better localization of the guidewire in the bile duct, and thereby 18 
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shorten the X-ray fluoroscopy time and procedure time while minimizing radiation 1 
exposure and complications. 2 
 3 
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Percutaneous transhepatic biliary drainage (PTBD) is an established interventional 2 
procedure for treating patients with malignant or benign biliary obstruction [1-7]. A 3 
recent quality improvement guideline for PTBD reported that the threshold of success 4 
rate for dilated ducts is 95% [5]. However, PTBD is an invasive technique and has some 5 
associated complications [6]. The recommended overall procedure threshold for all 6 
major complications of PTBD is 10% [5]. Complications can be categorized as “early” 7 
(i.e., occurring within 30 days) or “late”. Approximately one-half of early complications 8 
are procedure-related [8-10]. Thus, it is important that the procedure is performed 9 
precisely and quickly to reduce complications. 10 
We have used virtual fluoroscopic preprocedural planning (VFPP) as a new 11 
navigation system to perform PTBD precisely and quickly. Virtual fluoroscopic 12 
preprocedural planning involves using an image in which trace lines are drawn along 13 
ductal structures (e.g., vessels or the biliary duct) on a Ray Summation image, which is 14 
similar to a fluoroscopy image, and it is easy to prepare using volume data from 15 
multiple-detector computed tomography (MDCT) and workstation [11]. Fukusumi et al. 16 
[11] reported the feasibility of VFPP in bronchoscopy. However, to our knowledge, 17 
there has yet been no report on the usefulness of VFPP in the PTBD procedure. 18 
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Therefore, the purpose of this study was to retrospectively evaluate the usefulness of 1 
VFPP in the PTBD procedure. 2 
 3 
Materials and Methods 4 
Patients 5 
Between April 2014 and April 2016 in the Department of Radiology at a single 6 
hospital, first-attempt PTBD was performed in 24 consecutive patients with obstructive 7 
jaundice due to biliary obstruction. We excluded 2 patients because the first-attempt 8 
PTBD was unsuccessful on account of the small caliber of the target duct. Thus, 22 9 
patients (11 men and 11 women; mean age, 76.8 years; range, 62–91 years) were 10 
included in this study. The causes of malignant biliary obstruction were pancreatic 11 
cancer (n = 7), cholangiocarcinoma (n = 3), lymph node metastasis of gastric cancer (n 12 
= 3), recurrent gastric cancer (n = 2), carcinoma of the ampulla of Vater (n = 1), 13 
gallbladder cancer (n = 1), and right renal pelvic cancer (n = 1). The cause of benign 14 
biliary obstruction was choledocholithiasis (n = 4). Twelve patients were treated by 15 
PTBD using intraoperative referencing coronal computed tomography (CT) images (i.e., 16 
coronal CT group) and 10 patients were treated by PTBD using intraoperative VFPP 17 
images (i.e., VFPP group). The institutional review board approved this retrospective 18 
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study and no individual patient consent was required. All patients were informed about 1 
the benefits and potential risks of the procedure. All patients provided written informed 2 
consent. 3 
 4 
The PTBD Procedure 5 
All procedures were performed by 2 interventional radiologists with at least 10 6 
years of experience with interventional techniques in the angiography suite. All patients 7 
were initially scanned by ultrasound (US) using a 3.5 MHz electronic convex probe 8 
(F37; Hitachi, Tokyo, Japan), and a CT scan was performed using the Somatom 9 
Sensation Cardiac 64 scanner (Siemens Medical Solutions, Forchheim, Germany). The 10 
PTBD procedures were administered in standard fashion, as described elsewhere [2, 3, 11 
10]. 12 
After administering local anesthesia with 1% lidocaine (Xylocaine Injection; 13 
AstraZeneca, Osaka, Japan) and intravenous sedation with pentazocine hydrochloride 14 
(Sosegon Injection; Maruishi Pharmaceutical, Osaka, Japan), a 18-gauge needle (Create 15 
Medic, Kanagawa, Japan) was inserted under US guidance using a 3.5MHz 16 
intraoperative electronic convex probe (F37; Hitachi, Tokyo, Japan) with a puncture 17 
adapter. Once the backflow of bile occurred and on successfully placing the needle tip 18 
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in the bile duct, a 0.035-inch guidewire (Radifocus; Terumo, Tokyo, Japan) was 1 
advanced into the proximal obstruction under X-ray fluoroscopy guidance while using 2 
the reference coronal CT images or VFPP images. After removing the needle, a 3 
7-French dilator (Cook Japan, Tokyo, Japan) and 7.2-French pigtail drainage catheter 4 
(Cook Japan, Tokyo, Japan) were inserted in order under X-ray fluoroscopy guidance. 5 
After placing the drainage catheter, a small amount of dilute contrast media was infused 6 
through the catheter to confirm that the catheter was in the appropriate position. If 7 
puncturing the targeted bile duct proved difficult, despite several attempts, then the 8 
other duct was punctured, and the change in protocol was recorded. If a guidewire could 9 
be advanced beyond the obstruction of the common bile duct, a 7.2-French pigtail 10 
drainage catheter, which was customized by adding side holes at the appropriate 11 
position (internal-external catheter), was placed into the small bowel. 12 
 13 
Coronal CT Imaging 14 
For all patients, MDCT was performed by using a Somatom Sensation Cardiac 64 15 
scanner. The range of CT covered the area of the abdomen. The scan and reconstruction 16 
parameters of CT were 64 × 0.6 mm beam collimation, 120 kV X-ray tube voltage, 250 17 
reference mAs of the X-ray tube current, and automatic exposure control (CARE Dose 18 
7 
 
4D; Siemens Medical Systems, Forchheim, Germany), 0.5-sec gantry rotation time, 1 
pitch factor of 1.1, 3.0 mm slice thickness, and reconstruction intervals of 3.0 mm. The 2 
convolution kernel was B31f medium smooth+. 3 
For the protocol with contrast material (CM), 600 mg iodine per kilogram body 4 
weight were injected for 30 seconds (20 [mg ∙ kg-1]/sec fractional dose) and the CT scan 5 
delay times were 45 seconds and 120 seconds. The CM was iopamidol 300 or iopamidol 6 
370 (Iopamiron with 300 mg or 370 mg of iodine per milliliter; Bayer Pharma, Osaka, 7 
Japan), depending on the patient’s weight. It was injected into the brachial vein with a 8 
22-gauge needle at a rate of 2.1–3.2 mL/sec using an automated injector (Dual Shot; 9 
Nemoto Kyorindo, Tokyo, Japan). 10 
Contrast-enhanced MDCT was performed to all patients with a malignant biliary 11 
obstruction (n = 18). However, plain MDCT was performed to all patients with a benign 12 
biliary obstruction (n = 4). 13 
 14 
Virtual Fluoroscopic Preprocedural Planning 15 
Since April 2015, we have used VFPP as a new navigation system. Virtual 16 
fluoroscopic preprocedural planning uses an image that is created from the volume data 17 
obtained from MDCT imaging with a workstation; the trace lines of the bile duct or 18 
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vessels on the Ray Summation image are similar to those of a fluoroscopy image [6]. 1 
Multidetector CT images of 1.0 mm thickness were transferred to a 3-dimensional 2 
workstation (SynapseVincent; Fujifilm Co., Tokyo, Japan). By referring to multiplanar 3 
reconstruction CT images, we drew a trace line between the targeted bile duct and the 4 
common bile duct before it enters the duodenum at the major duodenal papilla along the 5 
center of the bile duct. In addition, if necessary, we drew trace lines along neighboring 6 
bile ducts and added annotations at the obstruction and the major duodenal papilla. The 7 
lines could be displayed at any angle with 3-dimensional virtual fluoroscopic image. We 8 
reconstructed the background by using a Ray Summation image, and applied an edge 9 
filter (Figure 1). Customization of using workstation made it possible to create this 10 
image in approximately 10 minutes. All VFPPs were performed by 2 authors, and 11 
included a radiologist and radiological technician. In instances of disagreement, a final 12 
consensus was reached through interobserver discussion. We applied VFPP to the PTBD 13 
procedure. Virtual fluoroscopic preprocedural planning was used as a reference to select 14 
the bile duct during the PTBD procedure. 15 
 16 
Assessment 17 
To analyze the effect of the intraoperative referencing VFPP image, 10 consecutive 18 
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patients who had undergone first-attempt PTBD using VFPP (i.e., VFPP group) were 1 
retrospectively compared with 12 consecutive patients who had undergone first-attempt 2 
PTBD using coronal CT images (i.e., coronal CT group). The Fisher’s exact test or 3 
Mann–Whitney U test was used to evaluate significant differences in the patients’ 4 
characteristics and results of the PTBD procedure in the coronal CT and VFPP groups. 5 
Categorical variables are expressed as the number and compared by Fisher’s exact test. 6 
Continuous variables are expressed as the mean ± the standard deviation and 7 
compared by the Mann–Whitney U test. The patients’ characteristics that were 8 
examined were age, sex, body weight, etiology (i.e., benign or malignant biliary 9 
obstruction), location of the obstructing lesion (i.e., upper or lower), ascites, liver 10 
toxicity, inflammation, and jaundice. We classified the location of the obstructing lesion 11 
into 2 categories, based on the intraoperative cholangiopancreatography findings: (1) 12 
the “upper” location indicated that the obstructing lesion was above the point of the 13 
communication of the 3 ducts (i.e., cystic, common hepatic, and common bile duct) and 14 
(2) the “lower” location indicated that the obstructing lesion was below the point of the 15 
communication of the 3 ducts. Liver toxicity was evaluated by the aspartate 16 
aminotransferase (AST) and alanine aminotransferase (ALT) levels; inflammation was 17 
evaluated by white blood cell counts and C-reactive protein levels; and jaundice was 18 
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evaluated by the serum total bilirubin level by laboratory tests that were performed 1 
within 2 days before the PTBD procedure. Percutaneous transhepatic biliary drainage 2 
involved the targeted bile duct, diameter of the bile duct, depth of the bile duct, 3 
breath-holding ability (i.e., good or poor), number of targeted bile duct puncture 4 
attempts, change in the targeted bile duct, exchange of the drainage catheter, X-ray 5 
fluoroscopy time, and procedure time. We classified breath-holding into 2 grades, 6 
according to our instructions: (1) “good” was defined as breath-holding for more than 3 7 
seconds and (2) “poor” was defined as breath-holding for less than 3 seconds. We 8 
defined the procedure time as the time from the administration of the local anesthesia 9 
until confirming, using the contrasting media, that the catheter was in the appropriate 10 
position. Statistical significance was based on 2-sided design-based tests evaluated at α 11 
= 0.05. All statistical analyses were performed using SPSS, version 23 (IBM, Armonk, 12 
NY, USA). 13 
 14 
Results 15 
The Patients’ Characteristics 16 
The characteristics of both patient groups are presented in Table 1. There were no 17 




Results of the PTBD Procedure 2 
The results of PTBD procedure of both groups are presented in Table 2. The targeted 3 
bile duct was B3 or B8. In the coronal CT group, B3 was targeted in 8 patients and B8 4 
was targeted in 4 patients. In the VFPP group, B3 was targeted in 9 patients and B8 was 5 
targeted in one patient. There were no statistically significant differences between the 6 
groups. 7 
It was necessary to change the targeted bile duct in 2 patients in the coronal CT 8 
group and in one patient in the VFPP group because we failed to puncture the bile duct. 9 
There were no statistically significant differences between the groups. 10 
There were also no significant differences in the targeted bile duct, diameter and 11 
depth of target bile, breath-holding, number of puncture attempts, change in the targeted 12 
bile duct, and exchange of the drainage catheter. The X-ray fluoroscopy time and the 13 
procedure time were significantly shorter in the VFPP group than in the coronal CT 14 
group (196 seconds vs. 334 seconds, P < 0.05; and 16.0 minutes vs. 27.2 minutes, P < 15 
0.05). 16 
There were 6 procedure-related minor complications (Society of Interventional 17 
Radiology [SIR] Classification B). One patient in each group developed mild pain at the 18 
12 
 
puncture site and 2 patients in each group developed mild abdominal pain. One 1 
procedure-related major complication (SIR Classification D) occurred. One patient in 2 
the coronal CT group experienced subcapsular hepatic hematoma, but this patient was 3 
successfully treated conservatively. 4 
 5 
Discussion 6 
The importance of using imaging in preprocedural planning for patients with bile 7 
duct obstruction cannot be overemphasized because the level of obstruction and bile 8 
duct anatomy are most easily determined by MDCT or by magnetic resonance 9 
cholangiopancreatography [7]. However, it is impossible by MDCT to display the bile 10 
duct anatomy and obstruction in one image. Magnetic resonance 11 
cholangiopancreatography displays the bile duct anatomy and obstruction in one image, 12 
but the image is not similar to a fluoroscopy image. By contrast, a VFPP image displays 13 
the bile duct anatomy and obstruction in only one image that is similar to a fluoroscopy 14 
image (Figure 2). Because the lines can be displayed at any angle in the 3-dimensional 15 
virtual fluoroscopic image, we could also choose an appropriate working angle 16 
beforehand and perform the procedure in this state (Figure 3). Moreover, VFPP images 17 




Using intraoperative referencing VFPP images enables a physician to advance the 2 
guidewire precisely and quickly into the common bile duct under X-ray fluoroscopy 3 
guidance. Therefore, it was possible to shorten the X-ray fluoroscopy time and 4 
procedure time by using VFPP. Shortening the X-ray fluoroscopy time may contribute 5 
to lower amounts of radiation exposure to the patient and staff. 6 
One-half of early complications are procedure-related [8-10]. These complications 7 
include pain at the puncture site, bile leak with the risk of biliary peritonitis and biloma 8 
formation, cholangitis, septicemia, and bleeding [9, 10]. Adequate preprocedural 9 
planning may help to reduce these complications. 10 
New navigation systems are used in various procedures. The feasibility of 11 
automated tumor-feeders detection software for hepatocellular carcinoma and 12 
fluoroscopy with magnetic resonance angiography/computerized tomographic 13 
angiography fusion guidance for peripheral artery interventions have been reported in 14 
the literature [12-14]. These navigation systems are quite useful, but they are not 15 
available at all medical institutions. By contrast, VFPP is easy to prepare if only the 16 
volume data from MDCT and a workstation are available [11]. The introduction of a 17 
new device is therefore unnecessary, and an extra financial burden is avoided. 18 
14 
 
In this study, we were able to create VFPP from contrast-enhanced MDCT in all 1 
patients, except for one patient. All bile ducts were dilated. However, VFPP may take a 2 
long time if only plain MDCT images are available or if the bile duct does not dilate. 3 
In this study, the X-ray fluoroscopy time was 73–783 seconds (mean time, 4 
271seconds). Kloeckner et al. [15] reported that the mean X-ray fluoroscopy times of 5 
right- and left-sided PTBD were 13.5 minutes and 16.6 minutes. The mean PTBD time 6 
was longer in that study than in our study. There are 2 reasons for this finding. First, we 7 
performed PTBD in a one-step method using an 18-gauge needle instead of in the 8 
two-step method because all patients in this study had dilated ducts [10]. Second, in 9 
only 2 patients, we placed the internal-external catheter beyond the obstruction of the 10 
common hepatic duct, and we placed the obligatory external drainage catheter above the 11 
obstruction in many patients. 12 
This study had several limitations. First, it was a single-center study. Second, the 13 
retrospective nature of the study may also limit the conclusions drawn from it. Third, 14 
the number of patients in the VFPP group and CT group was uneven, which may have 15 
introduced bias in the results. However, the baseline characteristics of patients in both 16 
groups were equivalent. Fourth, the accuracy of VFPP depends on the planner because 17 
the lines in VFPP are drawn manually. However, all VFPP procedures were performed 18 
15 
 
by 2 authors, and included a radiologist and radiological technician. It was believed that 1 
the VFPP images were sufficient to be used as reference images. 2 
 3 
Conclusion 4 
Intraoperative referencing of the VFPP image during PTBD can intuitively be a 5 
useful tool for better localization of the guidewire in the bile duct. This procedure 6 
thereby shortens the X-ray fluoroscopy time and procedure time while minimizing 7 
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Fig. 1 The process of VFPP using a workstation. 
a and b While referencing the multiplanar reconstruction computed tomography images, 
we drew a trace line between the targeted bile duct, neighboring bile ducts, and common 
bile duct before it enters the duodenum at the major duodenal papilla along the center of 
the bile duct. c The background is a reconstructed Ray Summation image. d An edge 
filter is applied to the background 
VFPP, virtual fluoroscopic preprocedural planning 
 
Fig. 2 An 85-year-old female with obstructive jaundice due to pancreatic cancer. 
a We used this VFPP image as the reference image. The yellow line shows the course of 
B3 to the common bile duct. The annotation is the obstruction in the common bile duct. 
The blue lines show neighboring bile ducts. The VFPP image is similar to the 
fluoroscopy image. b The fluoroscopy image was obtained by infusing a small amount 
of dilute contrast media through the catheter 
VFPP, virtual fluoroscopic preprocedural planning 
 
Fig. 3 The VFPP makes it possible to display the three-dimensional virtual fluoroscopic 
2 
image at any angle.  
a The frontal view of B3 to the common bile duct. b The right anterior view (RAO) 25° 
of B3 to the common bile duct. c The left anterior view (LAO) 25° of B3 to the 
common bile duct 
VFPP, virtual fluoroscopic preprocedural planning 
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